EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial

Benjamin Duputel iD, Nigel Stallard, François Montestruc iD, Sarah Zohar iD, Moreno Ursino iD

Statistical Methods in Medical Research · 2023

DOI: 10.1177/09622802231160554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, 2023. Verfasst von Benjamin Duputel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Universitè Paris Citè, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Paris, France. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medical Research Council, Association Nationale de la Recherche et de la Technologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Master protocol designs allow for simultaneous comparison of multiple treatments or disease subgroups. Master protocols can also be designed as seamless studies, in which two or more clinical phases are considered within the same trial. They can be divided into two categories: operationally seamless, in which the two phases are separated into two independent studies, and inferentially seamless, in which the interim analysis is considered an adaptation of the study. Bayesian designs are scarcely studied. Our aim is to propose and compare Bayesian operationally seamless Phase II/III designs using a binary endpoint for the first stage and a time-to-event endpoint for the second stage. At the end of Phase II, arm selection is based on posterior (futility) and predictive (selection) probabilities. The results of the first phase are then incorporated into prior distributions of a time-to-event model. Simulation studies showed that Bayesian operationally seamless designs can approach the inferentially seamless counterpart, allowing for an increasing simulated power with respect to the operationally frequentist design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignBayes TheoremComputer SimulationClinical Trials, Phase II as TopicClinical Trials, Phase III as Topic

Stichwörter der Autor:innen

Bayesian confirmatory trialsdifferent outcomesoperating characteristicstreatment selection

Autor:innen und Institutionen

  • Universitè Paris Citè, Sorbonne Université, Inserm, Centre de Recherche des Cordeliers, Paris, France.
  • Inria, HeKA, Paris, France.
  • eXYSTAT, Malakoff, France.
  • Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK.
  • Unit of Clinical Epidemiology, Assistance Publique-Hôpitaux de Paris, CHU Robert Debrè, Paris, France.

ORCID-Profile: Benjamin Duputel, François Montestruc, Sarah Zohar, Moreno Ursino

Förderung

  • Medical Research Council
  • Association Nationale de la Recherche et de la Technologie

Zitieren

APA

Duputel, B., Stallard, N., Montestruc, F., Zohar, S., & Ursino, M. (2023). Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802231160554

Vancouver

Duputel B, Stallard N, Montestruc F, Zohar S, Ursino M. Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial. Statistical Methods in Medical Research. 2023. doi:10.1177/09622802231160554

BibTeX
@article{Duputel2023,
  author = {Duputel, Benjamin and Stallard, Nigel and Montestruc, François and Zohar, Sarah and Ursino, Moreno},
  title = {Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial},
  journal = {Statistical Methods in Medical Research},
  year = {2023},
  doi = {10.1177/09622802231160554}
}
Kostenlos starten →